US halts AstraZeneca vaccine production at Baltimore plant: report

The US government on Saturday arrested a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson’s Covid-19 vaccine by manufacturing the vaccine developed by AstraZeneca Plc, the New York Times reported.
J&J said in a statement that it “takes full responsibility for manufacturing the drug substance for its Covid-19 vaccine at the Emergent BioSolutions Inc. plant in Bayview.”
He did not say whether he will take over the plant. The company did not respond to Reuters requests for comment for clarification.
The New York Times reported that AstraZeneca said in a statement that he will work with President Joe Biden’s administration to find an alternative site. The drugmaker did not respond to a request for comment.
The decision by the US Department of Health and Human Services will make the Emergent BioSolutions facility solely devoted to manufacturing the Johnson & Johnson single-dose vaccine, and is aimed at avoiding future confusion, according to the journal’s report, which cites two. senior federal health official
The U.S. government’s leading infectious disease physician told Reuters the country may not need AstraZeneca’s vaccine even if it gets approval.